Predictive Oncology Announces Chief Business Officer Transition
Company Announcements

Predictive Oncology Announces Chief Business Officer Transition

Predictive Oncology Inc (POAI) has released an update to notify the public and investors about its officers.

Predictive Oncology Inc. will see the departure of its Chief Business Officer, Dr. Pamela Bush, by February 15, 2024. The company is actively seeking a replacement as part of its ongoing strategy for corporate development, signaling a commitment to maintaining its momentum in the business landscape.

For further insights into POAI corporate activity, check out TipRanks’ Insiders Trading Activity page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TipRanks Auto-Generated NewsdeskPredictive Oncology Inc. Reports Q3 2024 Earnings
TheFlyPredictive Oncology reports Q3 EPS (48c) vs (78c) last year
TheFlyPredictive Oncology board initiates process to evaluate strategic alternatives
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App